Parth Patwari

Medical Director, Clinical Sciences, Rare Diseases and Hematology
Takeda Development Center Americas, Inc., Cambridge, MA, USA
Cambridge, Massachusetts, United States

Presentation(s):

• OC 14.4 - Recombinant ADAMTS13 prophylaxis in patients with congenital thrombotic thrombocytopenic purpura: interim analysis from phase 3b continuation study

  Sunday, June 25, 2023
  11:30 – 11:45 ET